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The flavoprotein nitroalkane oxidase (NAO) from Fusarium oxy-
sporum catalyzes the oxidation of nitroalkanes to the respective
aldehydes with production of nitrite and hydrogen peroxide. The
sequences of several peptides from the fungal enzyme were used
to design oligonucleotides for the isolation of a portion of the NAO
gene from an F. oxysporum genomic DNA preparation. This se-
quence was used to clone the cDNA for NAO from an F. oxysporum
cDNA library. The sequence of the cloned cDNA showed that NOA
is a member of the acyl-CoA dehydrogenase (ACAD) superfamily.
The members of this family share with NAO a mechanism that is
initiated by proton removal from carbon, suggesting a common
chemical reaction for this superfamily. NAO was expressed in
Escherichia coli and the recombinant enzyme was characterized.
Recombinant NAO has identical kinetic parameters to enzyme
isolated from F. oxysporum but is isolated with oxidized FAD rather
than the nitrobutyl-FAD found in the fungal enzyme. NAO purified
from E. coli or from F. oxysporum has no detectable ACAD activity
on short- or medium-chain acyl CoAs, and medium-chain acyl-CoA
dehydrogenase and short-chain acyl-CoA dehydrogenase are un-
able to catalyze oxidation of nitroalkanes.
The flavoprotein nitroalkane oxidase (NAO; ref. 1) from thefungus Fusarium oxysporum (ATCC 695) catalyzes the oxi-
dation of nitroalkanes to the corresponding aldehydes or ke-
tones, hydrogen peroxide, and nitrite (Scheme 1). The likely
physiological role of the enzyme, which is induced when the
fungus is grown in the presence of a nitroalkane (2), is to protect
the fungus from nitroalkanes produced by plants as defensive
toxins (3). When isolated from fungal cells, the FAD cofactor in
NAO is in the form of a 5-nitrobutyl-1,5-dihydro-FAD (4). This
form of the enzyme is inactive, but it is converted to an active
form upon the decay of the adduct to yield FAD. The ability of
NAO to catalyze the oxidation of neutral nitroalkanes is unique
among flavoproteins studied to date (5). Studies of the mecha-
nism of formation of the flavin adduct and steady-state kinetic
isotope effects with the active enzyme are consistent with
substrate oxidation involving cleavage of the CH bond of the
substrate to form a carbanion. Although carbanion intermedi-
ates have been proposed for other flavoprotein oxidases, in
virtually all cases, the data can be accommodated equally well or
better by a hydride transfer mechanism (6). The much lower pKa
value of a nitroalkane -proton vs. that in an amino or a hydroxy
acid makes formation of a carbanion by NAO far more ener-
getically favorable. Thus, this enzyme seems to present a unique
opportunity for study of carbanion formation during catalysis by
a flavoprotein. Moreover, inasmuch as nonenzymatic carbanion
formation from nitroalkanes has been heavily studied as a model
for ionization of carbon acids (7), study of the mechanism of the
enzyme-catalyzed reaction can provide insights into the basis for
the increased rates of the latter.
Until now, the only structural information regarding NAO has
been its N-terminal sequence and the sequence of a putative
active-site peptide (8, 9); this has been sufficient to rule out the
existence of homologous proteins in the available databases,
which do not include F. oxysporum. We describe here the cloning
of the fungal enzyme, its expression in Escherichia coli, and the
mechanistic and evolutionary insights provided by knowledge of
its amino acid sequence.
Materials and Methods
Materials. Nitroethane, nitropropane, and nitromethane were
obtained from Aldrich. Phenylmethylsulfonyl f luoride and FAD
were obtained from Sigma. DTT was obtained from Research
Organics. Isopropyl -D-thiogalactopyranoside (IPTG) was
from Inalco Pharmaceuticals, San Luis Obispo, CA; l-1-
tosylamido-2-phenylethyl chloromethyl ketone-treated trypsin
was purchased from Worthington; butyryl and octanoyl CoA
were obtained from Sigma. Oligonucleotides were custom syn-
thesized on an Applied Biosystems model 380B DNA synthesizer
by the Gene Technology Laboratory of the Biology Department
of Texas A&M University. Restriction endonucleases NcoI,
SphI, PstI, HindIII, BamHI, and T4 ligase were obtained from
New England Biolabs; Pfu DNA polymerase was obtained from
Stratagene; Taq polymerase was from Promega or Qiagen,
Chatsworth, CA. Plasmids were purified by using mini- and
midi-kits from Qiagen. Nytran membranes were purchased from
Schleicher & Schuell. -32P-dATP was obtained from Amer-
sham Pharmacia; leupeptin, pepstatin, and lysozyme were ob-
tained from Roche Molecular Biochemicals; DEAE-Sepharose
Fast Flow was purchased from Amersham Pharmacia. E. coli
strain BL21(DE3) from Novagen was used for protein expres-
sion; strains NovaBlue (Novagen) and XL1-Blue (Stratagene)
were used during DNA cloning protocols. DNA sequencing was
carried out with the Applied Biosystems BigDye kit and analyzed
by the Gene Technology Laboratory of the Biology Department
of Texas A&M University. NAO was purified from F. oxysporum
(ATCC 695) as described (10). The activated FAD-containing
form of the enzyme was prepared according to Gadda et al. (4).
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Human kidney medium-chain acyl-CoA dehydrogenase
(MCAD) and Bacillus subtilis short-chain acyl-CoA dehydroge-
nase (SCAD) were generous gifts from Colin Thorpe (Univ. of
Delaware, Newark) and Marian Stankovich (Univ. of Minne-
sota, Minneapolis), respectively.
Isolation of Partial NAO Gene. F. oxysporum was grown in 500 ml
of yeast extract-peptone-dextrose medium (YEPD) medium
with 0.5 ml nitroethane at 28°C for 24 h. The DNeasy plant maxi
kit (Qiagen) was used to isolate genomic DNA from 0.33 g cells.
This genomic DNA was used as the starting template for two
sequential PCRs using Taq polymerase. The primers for the first
reaction were GTIGAYTTYAARYTIWSNCC and GGIC-
CISWIGTNGTDATRTG. The second reaction was carried out
with the product of the first reaction as template and the primers
AGTCTAAAGCTTCARGCITTYGCIAAYACNGT and
CTAAGTGGATCCGGYTCICCIARDATYTGRTA. The final
DNA product from these reactions (about 700 bp) was digested
with BamHI and HindIII and ligated into pUC18. Twelve
plasmids (pUCNAO1 through pUCNAO12) that contained the
sequences of the oligonucleotides from the second PCR were
sequenced from the BamHI site to the HindIII site.
Isolation of NAO cDNA. F. oxysporum was grown in 1 liter YEPD
medium with 0.1% nitroethane at 28°C; aliquots were removed
after 38, 47, 62, 71, 86, and 110 h. The cells (4 g for each time
point) were harvested, and RNA was isolated from about 200 mg
cells for each time point with the RNeasy plant kit from Qiagen;
mRNA then was isolated with the Oligotex kit from Qiagen. To
ascertain the optimal incubation time to obtain an mRNA
preparation enriched in the mRNA for NAO, a 5 g sample of
mRNA for each time point was analyzed by probing a Northern
blot. The probe used was the radioactively labeled 700 bp
BamHI–HindIII fragment from pUCNAO9.
Three grams of cell pellet from the 110-h time point was used
for a scaled-up RNA preparation followed by mRNA prepara-
tion using the same protocols. The resulting mRNA was sent to
Stratagene to construct a custom cDNA library in the Uni-ZAP
XR  vector. A  suspension (1.5  1010 plaque-forming
unitsml) that resulted from one amplification of this original
library was used as the template for all further cloning.
Two PCRs were performed on the cDNA library with Qiagen
HotStarTaq. Oligonucleotide primers based on internal se-
quences obtained from the genomic DNA, GACAACGCATG-
CAAGATCAGCCCC’ and CCCGTGATTCTTTGCGAT-
TCACC, and flanking sequences from the Uni-ZAP vector were
used. The products were purified with the QIAquick kit and
sequenced in both directions.
The cDNA for NAO was subcloned directly from the  library
into the expression vector pET21d by generating a PCR product
that contained the entire coding region flanked by EcoRI and
BamHI sites. The PCR used the primers TAGTTACACTTTC-
CAGTACTTGGATCCAATGGTTGACTTCAAACTTTC
and AGATTCTTATGTATGATGAATTCGACACCAT-
CACAGGCGAGATTT. The PCR product was purified, di-
gested with BamHI and EcoRI, purified again, sequenced in its
entirety in both directions, and ligated into pET21d. The correct
construct, pETNAO1, was sequenced in both directions from the
BamHI to the EcoRI site.
The internal NcoI site of the NAO cDNA was removed from
pETNAO1 by translation-silent mutagenesis with the Stratagene
QuikChange method. Next, a new NcoI site at the start codon
was introduced with the same method. The resulting plasmid was
digested with NcoI and religated. This step aligned the start
codon of the NAO cDNA optimally with the T7 RNA polymer-
ase promoter. This plasmid, pETNAO4, was sequenced from the
T7 promoter to the T7 terminator to confirm the cDNA
sequence. Competent E. coli strain BL21(DE3) cells were trans-
formed with plasmid pETNAO4.
Expression of NAO in E. coli. A single colony of E. coli strain BL21
(DE3) transformed with pETNAO4 was used to inoculate 50 ml
of LB containing 100 gml carbenicillin at 37°C. The starter
culture was grown for 10–12 h; 5 ml were used to inoculate 1 liter
of LB containing 100 gml ampicillin at 37°C. When the A600
value of the culture reached 0.7, IPTG was added to a final
concentration of 0.25 mM and the temperature of the culture was
lowered to 25°C. After 7 h, cells were harvested by centrifugation
at 5,000  g and 4°C for 25 min and stored at 80°C. Typically,
6 liters of culture yielded approximately 45 g of cells. The cells
were suspended in four volumes of 50 mM sodium phosphate, 1
mM EDTA, 0.1 mM FAD, 0.1 mM DTT, 0.1 mgml phenyl-
methylsulfonyl f luoride, 25 gml lysozyme, 5% glycerol at pH
7.0. The suspension was sonicated for 10 min on ice and
centrifuged at 10,000  g for 1 h. The cell-free extract was
incubated with 2% streptomycin sulfate for 20 min and centri-
fuged at 10,000  g for 20 min. Proteins precipitating between
40% and 65% ammonium sulfate saturation were collected. The
ammonium sulfate pellet was resuspended in 50 ml of buffer A
(20 mM Hepes1 mM EDTA5% glycerol, pH 8.0) containing
0.1 mM FAD and were dialyzed against buffer A. The sample
was loaded onto a DEAE-Sepharose Fast Flow column (2.7 
16 cm) that had been preequilibrated with 1 liter of buffer A. The
column was washed with 300 ml of buffer A plus FAD and eluted
with a linear gradient from 0–200 mM NaCl (750 ml total) in the
same buffer. Fractions with greater than 10% of the peak activity
were pooled and then were concentrated by precipitation at 70%
ammonium sulfate saturation. The pellet was resuspended in 5
ml of buffer A and dialyzed against 1 liter of the same buffer for
2 h. The purified enzyme was stored at 80°C.
Assays. The concentration of NAO was determined by the
method of Bradford (11) with BSA as standard. The concen-
tration of active NAO with bound FAD was determined spec-
trophotometrically at 446 nm using an 446 value of 11,700 M1
cm1 (4). NAO activity was measured with 25 mM nitroethane
as substrate in air-saturated 0.5 mM FAD50 mM potassium
phosphate, pH 7.0 or in 50 mM Hepes0.5 mM FAD, pH 8.0 by
monitoring the rate of oxygen consumption with a computer-
interfaced Hansatech Clark oxygen electrode (Hansatech In-
struments, Pentney King’s Lynn, U.K.) at 30°C, as described
(12). Concentrated solutions of substrate were prepared in
ethanol, and assays were initiated by the addition of substrate to
minimize the amount of nitroalkane anion present. Acyl-CoA
dehydrogenase (ACAD) activity was measured in 50 mM Hepes
at pH 8.0 by monitoring the reduction of ferrocenium hexaflu-
orophosphate at 300 nm, according to DuPlessis et al. (13).
Acyl-CoA oxidase activity was measured in 50 mM Hepes0.5
mM FAD, pH 8.0 by monitoring the rate of oxygen consumption
as described above.
Isolation of Tryptic Peptides of NAO. NAO (50 M) in 0.5 ml of
water was digested with trypsin [3% (wtwt) trypsinNAO].
After 4 h at 37°C, a second aliquot of trypsin [1% (wtwt) final
concentration] was added, and the mixture was allowed to react
for a further 15 h at 37°C. The digestion was stopped with
trif luoroacetic acid (1% final concentration). Purification of
peptides was carried out by HPLC by using a Waters instrument
equipped with a model 996 photodiode array detector and a
Vydac 218TP54 (Vydac, Hesperia, CA; 4.6  250 mm) reverse-
phase column at a flow rate of 1 mlmin1. Eluent A was 0.05%
aqueous trif luoroacetic acid, and eluent B was 0.04% trif luoro-
acetic acid in acetonitrile. The chromatography was carried out
with a linear gradient from 5% to 50% B over 90 min. Peptides
were collected manually. Automated Edman degradation of
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purified peptides was carried out on a Hewlett-Packard G1000A
protein sequencer at the Protein Chemistry Laboratory of Texas
A&M University.
Results
Cloning of NAO. The N-terminal amino acid sequence of NAO has
previously been determined (8); this analysis was repeated to
extend the sequence through the first 35 residues. The sequence
of a tryptic peptide containing essential tyrosyl and cysteinyl
residues has also been described (14). Eleven additional tryptic
peptides were isolated and sequenced to aid in the design of PCR
primers for isolation of the gene. A nested PCR was then carried
out on the genomic DNA of F. oxysporum using primers based
on the N-terminal sequence of the protein and on pairs of
internal tryptic peptides. One pair of internal peptides allowed
isolation of a clean DNA product, 700 bp in length. In one
reading frame, this DNA would code for amino acid residues
19–35 of the nonrecombinant protein and a portion of the tryptic
peptide used to generate the PCR primer for the second
reaction, as well as three other tryptic peptides, confirming its
authenticity as a portion of the NAO gene.
Expression of NAO is induced by growth of F. oxysporum in
the presence of nitroethane (2). The partial gene was used as a
probe in a Northern analysis to measure changes in the level of
NAO mRNA in the fungal cells as a function of time after the
addition of nitroethane. This procedure showed the mRNA
reached a maximum between 86 and 110 h (results not shown).
Accordingly, mRNA was isolated from cells grown in the
presence of nitroethane for 110 h, and a cDNA library was
prepared in  Uni-ZAP (Stratagene).
Primers based on the sequences of the NAO gene fragment
and on the plasmid immediately outside the cDNA insert then
were used to isolate the intact cDNA by PCR. Several sources
of high-temperature polymerases were tested in isolating the
NAO cDNA from this library. The best results were obtained
when using Qiagen HotStarTaq, presumably because of the
increased priming stringency achieved when using a high-
quality enzyme in a hot-start protocol. Two PCR products
were obtained that enveloped the entire cDNA for NAO with
approximately 250 bp of overlap. The first, 644-bp long,
contained the 5 end of the cDNA and the entire previously
determined gene fragment. The second contained the 3 end
and was 1,156-bp long. These PCR products were sequenced
in their entirety in both directions. The first PCR product
coded for 7 of the 12 peptides sequenced directly. The second
PCR product coded for the remaining five peptides, one of
which was the previously identified active-site peptide (9, 14).
Fig. 1 shows the arrangement of the peptide-coding regions
within the entire cDNA. This arrangement would code for a
protein of molecular mass 48,028 Da, in agreement with the
molecular mass of the nonrecombinant enzyme of 47,955 Da
determined by mass spectrometry (8). In addition, the calcu-
lated amino acid composition agrees well with the previously
determined values (8). In comparing the sequences of the gene
fragment and the cDNA, an intron was discovered. A 51-bp
sequence from the gene fragment is not in the cDNA and does
not code for any of the tryptic peptides.
The program PSI-BLAST v.3.2 (15) was used to search the
nonredundant databases of protein sequences for related
proteins. All of the proteins identified in this search with E
scores better than 0.01 were members of the family of ACADs
or of unknown function. The pairwise identity of NAO to
individual members of the ACAD family was 23–27%, whereas
the similarities ranged from 41% to 46%, with equivalent
matches to mammalian and bacterial enzymes. (Individual
ACAD sequences show pairwise identities with one another as
low as 34%.) There was no difference in the alignment to
ACADs of different chain length specificity. A representative
sequence alignment of NAO with members of the ACAD
family is shown in Fig. 2. The similarities and identities are
The soxC protein has previously been identified as a member of the ACAD superfamily (1).
This enzyme catalyzes the oxidation of dibenzothiophene to the corresponding sulfone; its
mechanism is unknown. This enzyme was not among those identified in either our BLAST or
PSI-BLAST searches using the nitroalkane oxidase sequence, and its level of identity with NAO
is much lower than that of NAO to any individual ACAD. The soxC protein has a phenyl-
alanine in place of the active-site glutamate found in members of the ACAD family,
suggesting that its mechanism does not involve proton abstraction.
Fig. 1. Nitroalkane oxidase cDNA sequence and the derived amino acid sequence. Peptide sequences determined from the protein are underlined. The
active-site peptide is in bold.
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distributed evenly throughout the structures, ruling out an
alignment simply because of an FAD-binding domain. Several
gaps must be introduced into the ACAD sequences for suc-
cessful alignment of NAO, as indicated by dashes in the ACAD
sequences in Fig. 2. Analysis of the three-dimensional struc-
ture of pig kidney medium-chain ACAD showed that the
additional sequences in NAO at positions 181, 191, 218, and
327 of pig MCAD correspond to surface loops. The remaining
two insertions, at positions 142 and 377, also occurred in loops
that are partially accessible to the surface.
Characterization of NAO Expressed in E. coli. With knowledge of the
entire sequence, the cDNA for NAO was subcloned directly
from the  library into the expression vector pET21d by gener-
ating a PCR product that contained the entire coding region.
After confirmation that the sequence matched that obtained
from the library, this plasmid was used to express NAO in E. coli.
The recombinant enzyme was produced in large quantities
(greater than 4% of the total cell protein). It was possible to
simplify the previous purification protocol from two chroma-
tography columns to one; NAO eluted from DEAE-Sepharose
Fig. 2. Alignment of F. oxysporum NAO with selected ACAD. The initial alignment was done with the program CLUSTALW and the sequences of human MCAD,
LCAD, and SCAD; rat MCAD and SCAD; mouse MCAD; pig MCAD; Drosophila ACAD; C. elegans MCAD; and B. subtilis ACAD. The numbers for human SCAD and
pig MCAD are for the mature proteins, whereas those for NAO and B. subtilis ACAD begin with the N-terminal methionine. The active-site base in each is
underlined.
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in homogenous form as determined by denaturing PAGE (data
not shown). Approximately 40 mg of pure NAO can be obtained
from 6 liters of culture (Table 1).
NAO isolated from F. oxysporum contains 5-nitrobutyl-1,5-
dihydro-FAD, formed during induction of the enzyme in the
presence of nitroethane (8). In contrast, the FAD in the recom-
binant enzyme is in the oxidized state, with a spectrum indis-
tinguishable from that of the activated form of the nonrecom-
binant enzyme (Fig. 3). Incubation of 20 mM nitroethane in 200
mM Hepes at pH 8.0 for 24 h at 25°C generates an approximately
equimolar mixture of the neutral and anionic species. Addition
of this mixture to recombinant NAO for 1 h at 25°C resulted in
complete conversion of the enzyme-bound FAD to the 5-nitro-
butyl adduct with a spectrum identical to that of the enzyme
isolated from F. oxysporum (Fig. 3). The steady-state kinetic
parameters for nitroethane at pH 8.0 and 30°C are comparable
for the native and recombinant enzymes, with Vmax and Km values
of 14.1  0.7 s1 and 2.7  0.3 mM for recombinant NAO
compared with values of 10.9 s1 and 2.9 mM for the activated
nonrecombinant enzyme (8).
In light of the sequence similarity of NAO to the ACADs, the
ability of the enzyme to carry out the reactions catalyzed by
members of the family was determined. In the ACAD assay (13)
with 9 M recombinant NAO, there was no activity with up to
106 M butyryl-CoA or 59 M octanoyl-CoA as substrate.
Similarly, no oxygen consumption was observed in acyl-CoA
oxidase assays with up to 265 M butyryl-CoA or 150 M
octanoyl-CoA as substrate at concentrations of either fungal or
recombinant NAO up to 0.9 M. Neither acyl-CoA was an
inhibitor of NAO from either source with nitroethane as sub-
strate. Conversely, nitroethane was not a substrate for either
human MCAD (0.8 M) or B. subtilis SCAD (0.6 M) in either
the oxidase or dehydrogenase assays. Neither human MCAD nor
B. subtilis SCAD showed any activity in the NAO assay with
nitroethane, nitropropane, or phenylnitromethane as substrate.
Finally, there was no change in the flavin spectrum of human
MCAD in the presence of 10 mM nitropropane, and there was
no change in the spectrum of NAO upon addition of 626 M
butyryl-CoA.
Discussion
The sequence of NAO described here identifies the enzyme as a
member of the ACAD superfamily. Although the identity between
NAO and the members of the ACAD family is low, it is well above
that expected for random chance. Moreover, the identities are
distributed throughout the sequence, so that it is not simply due to
an FAD domain. The alignment shown in Fig. 2 shows that NAO
contains several short sequences not found in members of the
ACAD family. These additional sequences are found in regions
corresponding to surface loops in the latter, as is often the case of
enzymes with similar folds but slightly different sizes.
The assignment of NAO to the ACAD superfamily is fully
consistent with the mechanisms previously proposed for acyl-
CoA dehydrogenation and for nitroalkane oxidation. In the
catalytic mechanism of the ACAD’s glutamate 376 abstracts a
proton from the -carbon of the substrate, as a hydride is
transferred from the -carbon to the flavin (16). We have
previously proposed that the NAO reaction is initiated by
removal of the -proton from the nitroalkane substrate by an
active-site base to form a carbanion. Examination of the align-
ment shown in Fig. 2 shows that glutamate 376 of pig MCAD
corresponds to aspartate 402 of NAO, suggesting that the latter
residue is the active-site base in NAO. An essential tyrosine and
an essential cysteine have been identified previously in NAO by
modification with tetranitromethane and N-ethylmaleimide, re-
spectively (9, 14). These can now be identified as tyrosine 398
and cysteine 397. Although neither residue is conserved in the
members of the ACAD superfamily, the effects of their modi-
fication upon the activity of NAO further support the identifi-
cation of aspartate 402 as the base and the conclusion that NAO
shares the three-dimensional structure of the ACADs. Finally,
mutagenesis of NAO aspartate 402 to asparagine results in a
decrease in activity of three orders of magnitude, consistent
with this residue being intimately involve in catalysis (M.P.V. and
P.E.F., unpublished observations).
Given that catalysis by both NAO and the ACADs requires
proton abstraction from carbon, the question arises as to whether
the mechanistic similarities extend further. By analogy to the
ACAD mechanism, one can propose a mechanism for NAO in
which a hydride is transferred to the flavin from the  carbon of
the nitroalkane anion. Displacement of nitrite from this ni-
troalkene by hydroxide would form a tautomer of the aldehyde
product. However, nitromethane is a substrate for NAO, albeit
a slow one (12). This observation makes such a mechanism
unlikely. Thus, it seems that the overall fold used by NAO and
the various ACADs is designed for removal of a proton from a
substrate carbon, but the subsequent reactions depend upon the
specific enzyme. This possibility resembles the situation in the
enolase superfamily described by Gerlt and coworkers (17) in
which the common reaction is also proton abstraction from
carbon. In that case, a metal ion is used to aid in the enolization
of the substrate, thereby lowering the pKa value of the  proton
from 29 so that it can be removed by an enzymatic base.
The mechanisms by which enzyme specificities evolve are of
substantial interest. Several general mechanisms have been
proposed (17). In one, the substrate specificity of an enzyme is
retained while the catalytic mechanism is modified. In a second,
the precursor enzyme already catalyzes the critical initial chem-
istry, and the substrate specificity is modified. In a third model,
the same active-site architecture is adapted to different chem-
istries and binding specificities. The catalysis by both NAO and
ACAD of reactions in which an initial step involves proton
Table 1. Purification of nitroalkane oxidase from E. coli
Step
Total units,
mol
min1
Total
protein,
mg
Specific activity,
mol
min1mg1 Yield, %
Cell-free extract 679 842 0.8 100
40–65% (NH4)2SO4 622 504 1.2 92
DEAE-Sepharose 384 36 10.6 57
Fig. 3. UV-visible absorbance spectra of recombinant NAO as isolated (solid
line) and after reaction with a mixture of neutral and anionic nitroethane
(dashed line). Conditions: 50 mM Hepes at pH 8.0 and 25°C.
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abstraction from carbon is consistent with this second model for
evolution of enzymes, suggesting that other members of this
superfamily also may catalyze carbon-hydrogen bond cleavage as
an initial step.
There are clearly significant differences between the structure
of NAO and those of the ACADs, in that each is unable to
catalyze the reaction catalyzed by the other. Elucidation of the
structural bases for the differences in substrate specificity should
provide insight into the evolution of the members of this
superfamily. In addition, comparison of the structures of NAO
and the ACAD’s will provide insight into the fundamental
requirements for catalysis of proton abstraction from carbon by
the members of this superfamily.
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